idarubicin has been researched along with Chromosome-Defective Micronuclei in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afzal, M; Khan, F; Sherwani, AF | 1 |
| de Campos-Nebel, M; Elguero, ME; González-Cid, M | 1 |
2 other study(ies) available for idarubicin and Chromosome-Defective Micronuclei
| Article | Year |
|---|---|
Chromosomal aberration and micronucleus studies of two topoisomerase (II) targeting anthracyclines.
Topics: Antibiotics, Antineoplastic; Cells, Cultured; Chromosome Aberrations; Doxorubicin; Humans; Idarubicin; Lymphocytes; Micronuclei, Chromosome-Defective; Micronucleus Tests; Mutagens; Topoisomerase II Inhibitors | 2009 |
DNA-PKcs-dependent NHEJ pathway supports the progression of topoisomerase II poison-induced chromosome aberrant cells.
Topics: Animals; Cell Cycle; Cell Line; CHO Cells; Chromosome Aberrations; Cricetinae; Cricetulus; DNA Breaks, Double-Stranded; DNA Topoisomerases, Type II; Etoposide; G1 Phase; G2 Phase; Idarubicin; Micronuclei, Chromosome-Defective | 2012 |